Results: 66

Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma

Braz. j. med. biol. res; 49 (8), 2016
Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate of 5%. Biomarkers for the early detection of pancreatic cancer are urgently needed. Transforming growth factor-beta1 (TGF-β1) is elevated in the tissues and plasma of patients with PDAC. However, no studies systemically report p...

TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma

Biol. Res; 48 (), 2015
BACKGROUND: Transforming growth factor (TGF)-β is involved in many physiologic processes, it often promotes metastasis, and its high expression is correlated with poor prognosis. In the present study, we analyzed the correlation between transforming growth factor beta 1 (TGF-β1) expression and prognosi...

Ginandroblastoma multiloculado, negativo para CD99 en una niña de 12 años: caso clínico

Arch. argent. pediatr; 112 (4), 2014
Los ginandroblastomas son tumores del ovario extremadamente raros, los cuales comparten componentes de células de la granulosa y de células de Sertoli/Leydig. Se describe un caso de una niña de 12 años, quien presenta hemorragia uterina anormal y sensación de masa intraabdominal de crecimiento progr...

Avaliação do valor da relação do antígeno prostático específico livre e total no diagnóstico do câncer de próstata

Rev. AMRIGS; 48 (3), 2004
Introdução: Este estudo visa a determinar a importância da relação PSA livre (PSAL) / PSA total (PSA) como forma de diferenciar câncer de próstata (CAP) de hiperplasia prostática benigna (HPB) em homens com níveis séricos de PSA entre 4,1 e 10 ng/ml. Material e métodos: Entre 1999 e 2000, 140 ...